Safety and Efficacy of Fluocinolone Acetonide Intravitreal Implants
Completed · Phase 2/Phase 3
Conditions studied: Noninfectious Posterior Uveitis
In brief
This is a multi-center, randomized, double-masked, controlled study to evaluate the safety and efficacy of fluocinolone acetonide (FA) intravitreal implants for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye. An additional objective is to compare the safety and efficacy of two doses of fluocinolone acetonide.
Key facts
- Study ID
- NCT00407082
- Run by
- Bausch & Lomb Incorporated
- People needed
- 278
- Starts
- 2000-12-01
- Expected to finish
- 2005-09-01
- Last updated by the study team
- 2011-12-08
Who can join
Age: 6 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Males or non-pregnant females at least 6 years of age who had been diagnosed and treated for recurrent, non-infectious uveitis affecting the posterior segment of one or both eyes for at least 1 year prior to the start of the study, and had 'quiet' eyes at surgery
You may not qualify if…
- Coexisting medical or ocular conditions that would interfere with the study results
Where it is running
- Duke Eye Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.